XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net income $ 127,734 $ 61,098
Adjustments to reconcile net income to net cash, cash equivalents, and restricted cash used in operating activities:    
Depreciation and amortization 11,260 5,273
Loss on disposal of property, equipment, and software 261 235
Share-based compensation expense 3,689 9,283
Deferred income taxes 32,475 19,117
Amortization of debt issuance costs and debt discount 2,482 1,431
Write-off of debt issuance costs 2,570 0
Fair value adjustments to contingent earnout obligations 1,487 0
Non-cash lease expense 2,869 0
Changes in operating assets and liabilities:    
Accounts receivable (52,905) (17,057)
Commissions receivable (251,188) (142,454)
Other assets 4,349 1,420
Accounts payable and accrued expenses 26,223 12,896
Operating lease liabilities (2,631) 0
Other liabilities 30,378 6,726
Net cash used in operating activities (60,947) (42,032)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (6,520) (6,185)
Proceeds from sales of property and equipment 0 3
Purchases of software and capitalized software development costs (5,807) (4,443)
Acquisition of business (23,879) 0
Net cash used in investing activities (36,206) (10,625)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from revolving line of credit 0 85,975
Payments on revolving line of credit 0 (97,007)
Net proceeds from Term Loans 228,753 416,500
Payments on other debt (189) (2,432)
Proceeds from other debt 0 12,125
Proceeds from common stock options exercised and employee stock purchase plan 1,778 5,364
Cash dividends paid 0 (275,000)
Payments of tax withholdings related to net share settlement of equity awards (10,026) 0
Payments of debt issuance costs (885) (7,694)
Payment of contingent earnout liability (32,300) 0
Net cash provided by financing activities 97,331 135,714
NET INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH 178 83,057
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH—Beginning of period 368,870 570
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH—End of period 369,048 83,627
Reconciliation to the Consolidated Balance Sheets:    
Total cash, cash equivalents, and restricted cash 369,048 83,627
SUPPLEMENTAL CASH FLOW INFORMATION:    
Interest paid, net (18,309) (14,654)
Income taxes paid, net (121) (48)
Private Placement    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments of stock issuance costs (1,771) 0
IPO    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments of stock issuance costs (3,911) (2,117)
Secured Debt | Line of Credit    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments on other debt $ (84,118) $ 0